Act now to sell losing stocks, offset gains and work around the ‘wash-sale’ rule
Read more at MarketWatch
-
Year-end selling is hitting these 7 stocks. How their tax loss can be your gain.
Foot Locker, CVS Health and Charles River Laboratories are among hard-hit stocks that look ready to recover.MarketWatch - 5h -
In Alaska, Santa's helpers work around the clock to deliver holiday packages
During the holidays, there are 33 delivery planes a day which fly in and out of Anchorage, Alaska, carrying about 80,000 packages.CBS News - 23h -
Why Micron’s stock could be poised for a post-earnings gain — with one catch
One analyst is “very bullish” on Micron’s stock ahead of what could be a mixed report on Wednesday. But he cautioned that a post-earnings stock bump might not last long.MarketWatch - 3d -
Why Trump Won the Election---and Why He Now Better Act Quickly
Political analyst Charlie Cook says that the loss of moderating influences in both parties has come with a loss of self-awareness.The Wall Street Journal - Dec. 12 -
Ukraine war briefing: Kyiv confirms Russian gains around Pokrovsk
US suspects Moscow preparing another Oreshnik ballistic missile attack; Zelenskyy hails strike on Russian airfield and fuel works. What we know on day 1,023. Russian troops destroyed or captured ...The Guardian - Dec. 12 -
Amazon Is Now Selling Hyundai Vehicles Through Amazon Autos
Amazon’s partnership with Hyundai means you can use the e-retailer to purchase a brand-new car online. More manufacturers will be joining the new service, called Amazon Autos, next year.Wired - Dec. 10 -
Biden must act now to block Trump’s retribution threats
By shielding public servants from politically motivated prosecutions, Biden can reinforce the independence of the DOJ and demonstrate that justice cannot be wielded as a weapon of retribution.The Hill - Dec. 9 -
Lululemon stock jumps as international growth helps to offset slowing U.S. sales
Lululemon has been in a bit of a rough spot after the departure of its longtime Chief Product Officer Sun Choe.CNBC - Dec. 6 -
Terns’s stock soars as analysts cheer leukemia data — and predict more gains
The pharma company now has two positive proof-of-concept trials under its belt, including its weight-loss pill.MarketWatch - Dec. 4
More from MarketWatch
-
Banner year for fixed-income funds leaves TCW and Western Asset behind
MarketWatch - 3h -
Treasury yields end with second week of advances, with interest rates set to stay elevated in 2025
MarketWatch - 3h -
Oil prices score weekly losses on strong dollar, China demand worries
MarketWatch - 3h -
FedEx’s freight-unit spinoff offers ‘early Christmas’ to Wall Street
MarketWatch - 4h -
A laptop you can repair yourself — and other smart tech gifts for the holidays
MarketWatch - 4h